Tekla Healthcare Opportunities Fund Manager Performance Evaluation
| THQ Fund | USD 20.32 0.02 0.1% |
The entity has a beta of 0.69, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tekla Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tekla Healthcare is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tekla Healthcare Opportunities has generated negative risk-adjusted returns adding no value to fund investors. Even with relatively invariable technical indicators, Tekla Healthcare is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
...more1 | Investment Report - Stock Traders Daily | 11/15/2024 |
| Expense Ratio | 1.4700 |
Tekla |
Tekla Healthcare Relative Risk vs. Return Landscape
If you would invest 2,100 in Tekla Healthcare Opportunities on August 28, 2024 and sell it today you would lose (68.00) from holding Tekla Healthcare Opportunities or give up 3.24% of portfolio value over 90 days. Tekla Healthcare Opportunities is generating negative expected returns assuming volatility of 1.0485% on return distribution over 90 days investment horizon. In other words, 9% of funds are less volatile than Tekla, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Tekla Healthcare Current Valuation
Fairly Valued
Today
Please note that Tekla Healthcare's price fluctuation is very steady at this time. At this time, the fund appears to be fairly valued. Tekla Healthcare Opp has a current Real Value of $20.37 per share. The regular price of the fund is $20.32. We determine the value of Tekla Healthcare Opp from inspecting fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we recommend buying undervalued funds and selling overvalued funds since, at some point, fund prices and their ongoing real values will draw towards each other.
Tekla Healthcare's intrinsic value may or may not be the same as its current market price of 20.32, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.32 | Real 20.37 | Hype 20.27 |
The intrinsic value of Tekla Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tekla Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tekla Healthcare Opportunities helps investors to forecast how Tekla fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Healthcare more accurately as focusing exclusively on Tekla Healthcare's fundamentals will not take into account other important factors: Tekla Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tekla Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of funds, such as Tekla Healthcare Opportunities, and traders can use it to determine the average amount a Tekla Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0438
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | THQ |
Estimated Market Risk
| 1.05 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tekla Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tekla Healthcare by adding Tekla Healthcare to a well-diversified portfolio.
Tekla Healthcare Fundamentals Growth
Tekla Fund prices reflect investors' perceptions of the future prospects and financial health of Tekla Healthcare, and Tekla Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tekla Fund performance.
| Shares Outstanding | 41.34 M | ||||
| Price To Earning | 6.76 X | ||||
| Earnings Per Share | 2.71 X | ||||
About Tekla Healthcare Performance
Assessing Tekla Healthcare's fundamental ratios provides investors with valuable insights into Tekla Healthcare's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Tekla Healthcare is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the SP 1500 Healthcare Index and SP 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.Things to note about Tekla Healthcare Opp performance evaluation
Checking the ongoing alerts about Tekla Healthcare for important developments is a great way to find new opportunities for your next move. Fund alerts and notifications screener for Tekla Healthcare Opp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tekla Healthcare Opp generated a negative expected return over the last 90 days | |
| Latest headline from news.google.com: Investment Report - Stock Traders Daily |
- Analyzing Tekla Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tekla Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Tekla Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tekla Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tekla Healthcare's management team can help you assess the Fund's leadership.
- Pay attention to analyst opinions and ratings of Tekla Healthcare's fund. These opinions can provide insight into Tekla Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Tekla Fund
Tekla Healthcare financial ratios help investors to determine whether Tekla Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tekla with respect to the benefits of owning Tekla Healthcare security.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |